Line 171: | Line 171: | ||
<div> | <div> | ||
<h2>WEEK 3 (13.7. – 19.7.)</h2> | <h2>WEEK 3 (13.7. – 19.7.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
Line 178: | Line 209: | ||
<div> | <div> | ||
<h2>WEEK 4 (20.7. – 26.7.)</h2> | <h2>WEEK 4 (20.7. – 26.7.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
Line 184: | Line 246: | ||
<div> | <div> | ||
<h2>WEEK 5 (27.7. – 2.8.)</h2> | <h2>WEEK 5 (27.7. – 2.8.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
Line 192: | Line 285: | ||
<h1>AUGUST</h1> | <h1>AUGUST</h1> | ||
<h2>WEEK 6 (3.8. – 9.8.)</h2> | <h2>WEEK 6 (3.8. – 9.8.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
Line 198: | Line 322: | ||
<div> | <div> | ||
<h2>WEEK 7 (10.8. – 16.8.)</h2> | <h2>WEEK 7 (10.8. – 16.8.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
Line 205: | Line 360: | ||
<div> | <div> | ||
<h2>WEEK 8 (17.8. – 23.8.)</h2> | <h2>WEEK 8 (17.8. – 23.8.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
Line 211: | Line 397: | ||
<div> | <div> | ||
<h2>WEEK 9 (24.8. – 30.8.)</h2> | <h2>WEEK 9 (24.8. – 30.8.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
Line 219: | Line 436: | ||
<h1>SEPTEMBER</h1> | <h1>SEPTEMBER</h1> | ||
<h2>WEEK 10 (31.8. – 6.9.)</h2> | <h2>WEEK 10 (31.8. – 6.9.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
Line 225: | Line 473: | ||
<div> | <div> | ||
<h2>WEEK 11 (7.9. – 13.9.)</h2> | <h2>WEEK 11 (7.9. – 13.9.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
Line 232: | Line 510: | ||
<div> | <div> | ||
<h2>WEEK 12 (14.9. – 20.9.)</h2> | <h2>WEEK 12 (14.9. – 20.9.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
Line 238: | Line 546: | ||
<div> | <div> | ||
<h2>WEEK 13 (21.9. – 29.9.)</h2> | <h2>WEEK 13 (21.9. – 29.9.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
Line 246: | Line 584: | ||
<h1>OCTOBER</h1> | <h1>OCTOBER</h1> | ||
<h2>WEEK 14 (30.9. – 6.10.)</h2> | <h2>WEEK 14 (30.9. – 6.10.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
Line 252: | Line 620: | ||
<div> | <div> | ||
<h2>WEEK 15 (7.10. – 13.10.)</h2> | <h2>WEEK 15 (7.10. – 13.10.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
</div> | </div> | ||
Line 259: | Line 657: | ||
<div> | <div> | ||
<h2>WEEK 16 (14.10. – 19.10.)</h2> | <h2>WEEK 16 (14.10. – 19.10.)</h2> | ||
+ | <h3>Test 1A: Construction of pNorV and norR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 1B: Construction of promoters with esaboxes and esaR plasmids</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 2: AND gate promoter pNorV+esabox</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 3: Switch based on recombinases</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 4: AND gate promoter pNorV+LldO</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Test 5: switch based on Cpf1 system</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | |||
+ | <h3>Directed evolution</h3> | ||
+ | <p> | ||
+ | </p> | ||
+ | <h3>General</h3> | ||
+ | <p> | ||
+ | </p> | ||
</div> | </div> | ||
</div> | </div> |
Revision as of 17:53, 18 October 2016
NOTEBOOK
JULY
WEEK 1 (27.6. – 5.7.)
Test 1A: Construction of pNorV and norR plasmids
We ordered gBlocks for:
- norR without forbidden restriction sites
- two versions of pNorV: one with the native spacer after transcription start site and one without
Test 1B: Construction of promoters with esaboxes and esaR plasmid
We ordered gBlocks for promoters with esaboxes. E. coli colonies with plasmid with esaR from addgene arrived.
Test 3: Switch based on recombinases
We ordered gBlocks for 3 different codon optimized recombinases without forbidden restriction sites:
- bxb1
- phiC31 and
- tp901
General
- We ordered first oligos
- We prepared first TFB1 and TFB2 buffers for competent cells. The next day we prepared the first batch of competent TOP10 cells (80 transformations).
- We did first transformations:
- interlab study plasmids
- pSEVA backbone plasmids
- plasmids from distribution kit to get J23118 promoter, terminator, prefix and suffix
- Transformation of plasmids with fluorescent proteins we might use: sfGFP, mCherry, mNectarine, mTurqouise.
- Followed were first overnight cultures of transformations and first minipreps of the plasmids from transformations and addgene colonies.
- We prepared first batch of ingredients for M9 media.
- We poured first LB-agar plates with single resistances for carbenicillin, kanamycin and chloramphenicol.
WEEK 2 (6.7. – 12.7.)
Test 1A: Construction of pNorV and norR plasmids
We used two approaches to get norR and pNorV fragments:
- PCR to extract genomic copy of norR and pNorV
- PCR to multiply norR and pNorV from gblocks.
Test 1B: Construction of promoters with esaboxes and esaR plasmid
We did PCR to get a fragment with esaR from addgene plasmid and added overhangs to it.
Test 3: switch based on recombinases
We did site directed mutagenesis (PCR) to add ssRa tag to mNectarine and sfGFP.
Directed evolution: make EsaR specific to AHL present in the gut
- We prepared electro-competent DH5alpha -uptr cells.
- We transformed respective cells with plasmid with uracil phosphoribosyltransferase (upp or uptr).
- - We performed Tecan plate reader experiment to test the response of cells with and without the plasmid towards 5-fluorouracil. Upp/gfp plasmid is under control of dmpR/phenol.
- 5-FU had an inhibitory effect on growth with all concentrations. There was no growth difference between un-induced and induced state
- We attempted to construct CAT-UPTR fusion protein:
- We did PCR to get fragments with CAT (chloramphenicol resitance) and UPTR.
- We did Gibson asesembly of CAT and UPTR fragments to create fusion protein.
- We attempted to construct hsvTK (herpes simplex virus thimidine kinase)-APH-Stop-GFP operon:
- We did PCR to create APH and hsvTK fragments and performed Gibson assembly. Colony PCR did not show any results. However, since the cells grew, they were Amp resistant.
General
- We repeated failed transformations.
- We transformed additional pSEVA empty backbone plasmids.
- We did PCR to linearize pSEVA backbones and to get fragments with prefix + J23118 and terminator + suffix for Gibson assemblies.
- We did digestion to exchange oris on two plasmid backbones.
- Following all successful transformations we did overnight culture and minipreps.
WEEK 3 (13.7. – 19.7.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
WEEK 4 (20.7. – 26.7.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
WEEK 5 (27.7. – 2.8.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
AUGUST
WEEK 6 (3.8. – 9.8.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
WEEK 7 (10.8. – 16.8.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
WEEK 8 (17.8. – 23.8.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
WEEK 9 (24.8. – 30.8.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
SEPTEMBER
WEEK 10 (31.8. – 6.9.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
WEEK 11 (7.9. – 13.9.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
WEEK 12 (14.9. – 20.9.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
WEEK 13 (21.9. – 29.9.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
OCTOBER
WEEK 14 (30.9. – 6.10.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
WEEK 15 (7.10. – 13.10.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General
WEEK 16 (14.10. – 19.10.)
Test 1A: Construction of pNorV and norR plasmids
Test 1B: Construction of promoters with esaboxes and esaR plasmids
Test 2: AND gate promoter pNorV+esabox
Test 3: Switch based on recombinases
Test 4: AND gate promoter pNorV+LldO
Test 5: switch based on Cpf1 system
Directed evolution
General